master investor exhibitors

Rhinomed Limited (ASX: RNO)

Rhinomed is a medical technology company with a patented nasal technology platform that seeks to improve the way you breathe, sleep, maintain your health and take medication.

Rhinomed has two OTC, FDA accredited technologies, the Turbine® (aerobic exercise), and Mute® (to reduce snoring and improve sleep quality).

Rhinomed is currently in clinical trials for a low invasive, well-tolerated solutions for mild-moderate sleep apnoea, and a trial establishing the efficacy of the technology as an intranasal drug delivery platform.

Posted under: Exhibitors 2015

Comments are closed.